An increasing trend of risk score was observed with higher pathological stages ( Figure 4j ), patients with pathological stage IV disease had significantly elevated scores compared to those with stage I (p = 0.027) and stage II (p = 0.017).
← all excerpts
Integrative analysis of a novel snoRNA-based prognostic signature in patients with breast cancer.
1
—
—